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Appropriate Wnt morphogen secretion is required
to control animal development and homeostasis.
Although correct Wnt globular structure is essential
for secretion, proteins that directly mediate Wnt
folding and maturation remain uncharacterized.
Here, we report that protein disulfide isomerase-1
(PDI-1), a protein-folding catalyst and chaperone,
controls secretion of the Caenorhabditis elegans
Wnt ortholog EGL-20. We find that PDI-1 function is
required to correctly form an anteroposterior EGL-
20/Wnt gradient during embryonic development.
Furthermore, PDI-1 performs this role in EGL-20/
Wnt-producing epidermal cells to cell-non-autono-
mously control EGL-20/Wnt-dependent neuronal
migration. Using pharmacological inhibition, we
further show that PDI function is required in human
cells for Wnt3a secretion, revealing a conserved
role for disulfide isomerases. Together, these results
demonstrate a critical role for PDIs within Wnt-pro-
ducing cells to control long-range developmental
events that are dependent on Wnt secretion.
INTRODUCTION
Wnt glycoproteins are predominant regulators of metazoan cell
fate patterning and tissue assembly. During development, Wnt
proteins can form long-range concentration gradients to provide
positional and instructive information to surrounding cells (Cadi-
gan et al., 1998; Clevers, 2006). The scale and amplitude of Wnt
protein gradients require tight regulation, as aberrant gradient
formation is linked to developmental deficits and disease (Chris-
todoulides et al., 2006; MacDonald et al., 2014; Person et al.,
2010; Roifman et al., 2015). As such, there is great interest in
understanding how Wnt proteins are synthesized, modified,
secreted, and delivered to receiving cells.Cell R
This is an open access article under the CC BY-NWnt proteins are characterized by 24 invariantly positioned
cysteine residues that form intramolecular disulfide bonds to
maintain functional Wnt globular secondary structure (Miller,
2002; Willert and Nusse, 2012). Wnt protein synthesis and matu-
ration occur in the endoplasmic reticulum (ER) and Golgi appa-
ratus, facilitated by numerous processing enzymes and molecu-
lar chaperones (Braakman and Bulleid, 2011; Willert and Nusse,
2012). During Wnt maturation, complex folding events and
posttranslational modifications occur to support secretion and
formation of a Wnt concentration gradient (Janda et al., 2012;
Willert and Nusse, 2012). Biochemical characterization of
secreted Wnt revealed that Wnt proteins undergo functionally
important posttranslational modifications such as lipidation
and glycosylation (Caramelo and Parodi, 2007; Takada et al.,
2006; Willert et al., 2003). A particularly critical step for Wnt
protein maturation and secretion is acylation of a specific serine
residue by the membrane-bound O-acyltransferase called
Porcupine (Kadowaki et al., 1996; van den Heuvel et al., 1993).
Inhibiting Wnt protein acylation ablates Wnt signaling and
causes developmental defects (Barrott et al., 2011; Grzeschik
et al., 2007). Transfer of the acyl group toWnt proteins is required
for a functional interaction withWntless (Wls), which binds to and
conveys Wnt proteins to the cell surface—a critical process for
correct Wnt secretion (Ba¨nziger et al., 2006). Following delivery
of Wnt protein, Wls is recycled to the Golgi via endosomes and
the retromer complex where it may escort newly synthesized
Wnt to the cell surface (Belenkaya et al., 2008; Coudreuse
et al., 2006; Port et al., 2008; Prasad and Clark, 2006; Yang
et al., 2008). In Caenorhabditis elegans, studies have shown
that MIG-14/Wls and retromer complex components such as
VPS-35 are required for appropriate formation of an EGL-20/
Wnt gradient (Coudreuse et al., 2006; Yang et al., 2008). Further-
more, previous studies demonstrated that in the absence of ret-
romer complex function, MIG-14/Wls is degraded in lysosomes,
thereby limiting EGL-20/Wnt secretion (Yang et al., 2008). There-
fore, key molecular components and mechanisms controlling
Wnt secretion are highly conserved.
Wnt proteins play major roles in directing neuronal migration
and axon-dendritic guidance in vertebrates (Bocchi et al.,eports 26, 3183–3190, March 19, 2019 ª 2019 The Author(s). 3183
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. PDI-1 Controls HSN Migration
(A) EGL-20/Wnt forms a long-range morphogen
gradient to control HSN migration during embryo-
genesis. This paradigm provides a screening
platform to identify EGL-20/Wnt regulatory mole-
cules.
(B) pdi-1 RNAi knockdown causes HSN develop-
mental defects. n > 50; ***p < 0.001; n.s., not sig-
nificant (compared to vector control RNAi).
(C) HSN anatomy of young adults: control RNAi
(upper image) and pdi-1 RNAi (lower image). The
pdi-1 RNAi image shows the most common
phenotype observed (undermigration, white ar-
row) when pdi-1 expression is reduced (see Table
S1 for details). Ventral view, anterior is to the left.
Scale bar: 20 mm.
(D) Average position of the HSNs with respect to
seam cells V1.a to V6.p in wild-type and pdi-
1(gk271) animals (scored by Nomarski optics).
Values listed are percentiles of the total number of
cells scored; the red coded heatmap displays the
range of percentile values. n > 30; ***p < 0.0001.
(E) Quantification of HSN developmental defects
after exposure of wild-type and pdi-1(gk271) ani-
mals to the 16F16 PDI inhibitor. n > 50; ***p <
0.001; n.s., not significant.2017; Yoshikawa et al., 2003). In C. elegans, Wnt proteins also
control specific neurodevelopmental events, including neuron
migration, neuronal polarity, and axon guidance (Coudreuse
et al., 2006; Hilliard and Bargmann, 2006; Pan et al., 2006).
Furthermore, control of EGL-20/Wnt gradient formation by
MIG-14/Wls and the retromer complex is required to control
neuronal development (Coudreuse et al., 2006; Yang et al.,
2008). We therefore exploited the correlation between Wnt
gradient formation and neuronal development in C. elegans to
identify regulators of Wnt secretion.
Wnt proteins are rich in disulfide bonds that are mostly formed
during translation in the ER (Fass, 2012). Disulfide bonds
enhance Wnt stability in the proteolytic and oxidizing extracel-
lular environment to enable appropriate cell-to-cell communica-
tion. Coordination of disulfide bonds is a vital and pervasive step
during Wnt biogenesis, as previous studies demonstrated that
correct disulfide bond formation is required for Wnt secretion
(MacDonald et al., 2014; Zhang et al., 2012). This suggests
that regulatory enzymes that monitor and shuffle disulfide bonds3184 Cell Reports 26, 3183–3190, March 19, 2019would be essential for appropriate Wnt
secretion and signaling. Here, we identify
protein disulfide isomerases (PDIs) as
master controllers of Wnt secretion. Our
genetic and pharmacological analysis of
C. elegans PDI-1 reveal that it is required
for EGL-20/Wnt gradient formation and
controls EGL-20-directed neuron migra-
tion from EGL-20-producing epidermal
cells. We further demonstrate that PDI
function is conserved, as inhibition of
PDI in human cells specifically impairsWnt secretion. Together, we have identified PDIs as pervasive
regulators of Wnt secretion.
RESULTS
PDI-1, a PDI, Regulates Neuronal Migration
EGL-20/Wnt is expressed and secreted from a subset of
hypodermal (epidermal) and muscle cells in the posterior of
C. elegans (Whangbo and Kenyon, 1999) (Figure 1A). EGL-20
function is critical for specific neurodevelopmental events,
including anterior migration of the hermaphrodite-specific neu-
rons (HSNs) (Desai et al., 1988) (Figure 1A). We used HSN
development as a readout of EGL-20 function to identify mol-
ecules that control Wnt maturation and secretion (Figure 1).
PDIs are a family of protein chaperones that reside in the ER
to catalyze the formation (oxidation), breakage (reduction),
and rearrangement (isomerization) of disulfide bonds (Wilkin-
son and Gilbert, 2004). Due to the importance of disulfide
bond formation for Wnt secretion and function (MacDonald
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Figure 2. PDI-1 Regulates HSN Migra-
tion Cell-Non-Autonomously from the
Epidermis
(A) Genetic locus of pdi-1 showing gene structure
in black and gk271 genetic lesion in red. The
841-bp promoter used to drive gfp for expression
analysis is in green.
(B–I) Expression of a Ppdi-1::gfp transcriptional
reporter during embryonic development. Nomar-
ski micrographs (B–E) and fluorescence images of
the same embryos (F–I) are shown. Anterior is to
the left. Scale bar: 10 mm.
(J) HSN developmental defects of pdi-1(gk271)
mutant animals are rescued by transgenic
expression of pdi-1 cDNA controlled by its own
promoter and the hypodermal-specific dpy-7
promoter. Deletion of the ER retention motif
(HEEL) abrogates PDI-1 rescuing ability in the
hypodermis. n > 50; ***p = 0.001 for wild-type
compared to pdi-1(gk271);>>>p < 0.001; n.s.,
not significant for pdi-1(gk271) compared to
rescue lines. # refers to independent transgenic
lines. Scale bar: 10 mm.et al., 2014; Zhang et al., 2012), we hypothesized that PDIs
may be important for EGL-20-directed HSN development. Using
RNAi, we knocked down the expression of the five C. elegans
PDI-encoding genes (pdi-1, pdi-2, pdi-3, pdi-6, and C14B9.2)
and analyzed HSN development (Figures 1B and 1C). This
screen identified a specific requirement for pdi-1 during HSN
development, where 20% of pdi-1(RNAi)-treated animals
exhibit an HSN undermigration phenotype (Figures 1B and
1C). We confirmed the role of pdi-1 in HSN development using
a previously isolated pdi-1(gk271)-null allele (Figures 1D, 1E, 2A,
and S1; Table S1). As PDI proteins act as folding catalysts and
molecular chaperones, we hypothesized that elevated tempera-
ture would exacerbate improper folding events and adversely
affect HSN development. We indeed found that, in pdi-1() an-
imals, HSN defects progressively increase with elevated incuba-
tion temperature (Figure S1). EGL-20 controls HSN migration
during embryogenesis. To determine whether PDI-1 can also
control EGL-20-dependent postembryonic neuronal develop-
ment, we examined the post-embryonically migrating QR.pax
cell. We found that pdi-1() animals also exhibit defective migra-Cell Reption of QR.pax (Figure S2). Together, we
show that PDI-1 controls two tempo-
rally distinct EGL-20-regulated migration
events.
Using a previously reported PDI-spe-
cific 16F16 inhibitor, we asked whether
manipulation of PDI activity could affect
PDI-regulated HSN development in vivo
(Hoffstrom et al., 2010; Kaplan et al.,
2015). We found that 16F16 causes
HSN defects in wild-type animals similar
to that caused by loss ofpdi-1 (Figure 1E).
In contrast, when pdi-1() animals were
exposed to the PDI inhibitor, the HSN
phenotype was not enhanced (Figure 1E),suggesting that 16F16 causes HSN developmental defects by
inhibiting of PDI-1 activity in vivo.
PDI-1 Regulates HSN Migration from Epidermal Cells
HSN migration occurs between the comma and 1.5-fold
stages of embryogenesis (Desai et al., 1988). Using a GFP
transgenic reporter for pdi-1, we detected GFP in embryonic
hypodermis from the comma stage (Figures 2A–2I). We did
not detect neuronal expression, suggesting that pdi-1 regu-
lates HSN development cell-non-autonomously, as shown for
other guidance pathways (Kennedy et al., 2013; Pedersen
et al., 2013).
To investigate the PDI-1 focus of action, we first drove pdi-1
cDNA under the endogenous pdi-1 promoter in pdi-1() animals
and found that this fully rescued the pdi-1() HSN develop-
mental defects (Figure 2J). We found that driving pdi-1 cDNA un-
der the hypodermal-specific dpy-7 promoter also fully rescued
the HSN defects of pdi-1() animals (Figure 2J). PDI proteins
act in the ER lumen to catalyze protein folding and inhibit mis-
folded protein aggregation (Wilkinson and Gilbert, 2004). PDIorts 26, 3183–3190, March 19, 2019 3185
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Figure 3. PDI-1 Acts in the EGL-20/Wnt
Pathway to Direct HSN Migration
(A and B) HSN anatomy of egl-20(n585) (A) and
pdi-1(gk271) (B) mutant animals (HSN under-
migration, white arrows). Vulval position, red
asterisk. Ventral view, anterior is to the left. Scale
bar: 20 mm.
(C) Double-mutant analysis of Wnt morphogen
mutant strains in combination with pdi-1(gk271).
See Table S1 for detailed scoring. n > 50; ***p <
0.001 for wild-type compared to pdi-1 and egl-20
mutants; >>>p < 0.001 for pdi-1(gk271)
compared to pdi-1(gk271); lin-44(n1792) double
mutant; ###p < 0.001 for egl-20(n585) compared
to the egl-20(n585); lin-44(n1792) double mutant;
n.s., not significant.
(D and E) Expression of a Pegl-20::gfp transcrip-
tional reporter at the comma (D) and 3-fold (E)
stages of embryonic development in a subset of
posterior cells, as previously shown (Prasad and
Clark, 2006; Whangbo and Kenyon, 1999). Ante-
rior is to the left. Scale bar: 10 mm.
(F) HSN developmental defects of pdi-1(gk271)
mutant animals are rescued by transgenic
expression of pdi-1 cDNA controlled by the egl-20
promoter (used in D and E) but not by the lin-44
promoter, which expresses more posteriorly
(Klassen and Shen, 2007). n > 50; ***p = 0.001 for
wild-type compared to pdi-1(gk271); >>>p <
0.001; n.s., not significant for pdi-1(gk271)
compared to rescue lines. # refers to independent
transgenic lines.
(G–I) EGL-20::GFP expression and secretion
analysis.
(G) Schematic of a comma-stage embryo ex-
pressing EGL-20::GFP from a group of posterior
cells (green circles). EGL-20::GFP levels measured
in zones 1–3.
(H) Three-dimensional (3D) reconstruction and
heatmap of wild-type and pdi-1(gk271) mutant
comma-stage embryos expressing EGL-20::GFP.
Single slice of a Z stack from confocal microscopy
(left) and 3D reconstructed heatmaps of the same
embryos (center and right). EGL-20::GFP is rep-
resented from high (red) to low (blue).
(I) Corrected total EGL-20::GFP fluorescence
of wild-type and pdi-1(gk271) animals in each zone
of comma-stage embryos. n = 15; *p < 0.05; **p <
0.001.proteins contain a C-terminal ER-retention signal (His-Glu-Glu-
Leu or HEEL) that helps maintain their functional locale. We
deleted this ER retention signal (HEEL) in PDI-1 and found
that this abrogates the ability of PDI-1 to rescue the HSN devel-
opmental defects of pdi-1() animals (Figure 2J). Together, our
data show that PDI-1 acts within the ER of hypodermal cells to
cell-non-autonomously regulate HSN development.
PDI-1 and EGL-20/Wnt Control HSN Migration in the
Same Genetic Pathway
HSN migration defects of pdi-1() animals are comparable,
albeit less severe, to defects of egl-20/Wnt loss-of-function ani-
mals (Figures 3A–3C; Table S1) (Forrester et al., 2004). We used
genetic analysis to determine whether pdi-1 and egl-20 act in the3186 Cell Reports 26, 3183–3190, March 19, 2019same pathway to direct HSN development (Figure 3C; Table S1).
We examined the egl-20(n585) missense allele in which a
conserved cysteine is substituted to serine (C99S) (Maloof
et al., 1999). Mutation of this cysteine in human Wnt3a causes
reduced secretion and activity (MacDonald et al., 2014). We
show that egl-20(n585) causes highly penetrant defects
(75%) in HSN development (Figure 3C), as previously reported
(Desai et al., 1988; Forrester et al., 2004; Harris et al., 1996). The
pdi-1(); egl-20(n585) compound mutant had no enhanced
penetrance or expressivity of HSN defects compared to egl-
20(n585) (Figure 3C; Table S1), suggesting that these genes
act in the same genetic pathway. We considered that the pene-
trance of HSN defects observed in egl-20(n585) animals may
have reached a ceiling, and, as such, no enhancement of
phenotype was possible. However, when we introduced a LIN-
44/Wnt mutation into the egl-20(n585) mutant background, we
found that the egl-20(n585); lin-44(n1972) compound mutant
exhibits increased penetrance of HSN defects when compared
to egl-20(n585) (Figure 3C; Table S1), as previously shown (Zino-
vyeva et al., 2008). We also found the lin-44(n1972) mutation
enhances the pdi-1() HSN developmental defects (Figure 3C;
Table S1). Together, these data show that pdi-1 acts in the
same pathway as egl-20 and in parallel to lin-44 to control
HSN development.
HSN development is controlled by a complex network of Wnt
ligands and Frizzled receptors (Pan et al., 2006; Zinovyeva and
Forrester, 2005; Zinovyeva et al., 2008). The Frizzled receptors
MIG-1 and CFZ-2 act in a partially overlapping manner to
coordinate HSN development, where CFZ-2 function is only
revealed when MIG-1 is abrogated (Pan et al., 2006; Zinovyeva
et al., 2008). Loss of EGL-20 enhances HSN developmental
defects in a mig-1 mutant (Table S1) but not the cfz-2 mutant
(Zinovyeva and Forrester, 2005), suggesting that EGL-20 can
act on both receptors but predominantly on MIG-1. We found
that loss of PDI-1 in a mig-1 mutant causes fully penetrant
HSN migration defects (Table S1). In contrast, the penetrance
and expressivity of pdi-1(); cfz-2(ok1201) are no different
from pdi-1() (Table S1). Together, these data show that
PDI-1 acts through the same signaling pathway as EGL-20 to
direct HSN migration.
PDI-1 Functions in EGL-20/Wnt-Producing Cells to
Control HSN Migration
PDI-1 and EGL-20 are both expressed in the hypodermis, with
EGL-20 expression in a more restricted posterior region (Prasad
and Clark, 2006; Whangbo and Kenyon, 1999). If PDI-1 controls
EGL-20-directed HSN development, one may expect pdi-1 to
act in egl-20-producing hypodermal cells. We used the pub-
lished 1,900-bp egl-20 promoter (Harris et al., 1996) to drive
pdi-1 cDNA in egl-20-producing cells (Figures 3D and 3E) and
found that HSN developmental defects of pdi-1() animals
were fully rescued (Figure 3F). In contrast, expressing pdi-1
cDNA using the lin-44 promoter, in an adjacent and non-overlap-
ping subset of cells (Coudreuse et al., 2006; Klassen and Shen,
2007), was unable to rescue the pdi-1() HSN phenotype (Fig-
ure 3F). Thus, PDI-1 acts specifically from EGL-20-producing
hypodermal cells to control HSN development.
PDI-1 Controls EGL-20/Wnt Gradient Formation
Formation of an EGL-20 gradient is crucial for correct HSN and
Q cell migration in C. elegans (Coudreuse et al., 2006; Pan
et al., 2006). We hypothesized that loss of PDI-1 function could
affect the EGL-20 gradient. Three-dimensional reconstructions
of EGL-20::GFP localization in comma-stage embryos reveal
that EGL-20 forms an anteroposterior gradient (Figures 3H and
S3) (Coudreuse et al., 2006; Pan et al., 2006), and this gradient
is perturbed in pdi-1() animals (Figures 3H and 3I). Loss of
PDI-1 elevates EGL-20 localization adjacent to its site of expres-
sion with concomitant weaker distal expression (Figures 3G–3I
and S3). These results reveal that PDI-1 is involved in a key phase
of EGL-20 maturation within EGL-20-expressing cells to enable
EGL-20::GFP gradient formation.APDI Inhibitor DiminishesWnt3a Secretion fromHuman
Cells
Most mammalian genomes harbor 19 Wnt and over 20 PDI pro-
teins that exhibit diverse expression domains and biological
functions (Ellgaard and Ruddock, 2005; Galligan and Petersen,
2012; Willert and Nusse, 2012). Mammalian Wnt3a secretion is
abrogated when individual cysteine residues are substituted to
alanine (MacDonald et al., 2014), suggesting that Wnt secretion
is influenced by disulfide bond coordination.
To examine the functional conservation of PDIs, we inhibited
PDI function in human embryonic kidney cells (HEK293T) with
the 16F16 PDI inhibitor (Hoffstrom et al., 2010; Kaplan et al.,
2015) and assayed endogenous Wnt3a levels. Using a poly-
clonal anti-Wnt3a antibody (Abcam; ab199925), which we
validated using small interfering RNA (siRNA) knockdown of
Wnt3a (Figure S4A), we found that PDI inhibition caused
cellular accumulation of Wnt3a (Figures 4A and 4B) (Lim
et al., 2010; Vallier et al., 2009). This was not due to increased
transcription, as Wnt3a mRNA levels in 16F16-treated cells are
unchanged (Figure 4C). To assess Wnt3a secretion, we trans-
fected HEK293T cells with C-terminally V5-tagged Wnt3a
(Wnt3a-V5) (Figures 4D and 4E). The 16F16 PDI inhibitor
reduced Wnt3a-V5 secretion in a dose-responsive manner
(Figures 4D and 4E), with no detectable effect on cell viability
(Figure S4B). Conversely, we expressed FLAG-tagged TIG-2
(a bone morphogenetic secreted protein) in HEK293T cells
and found that the 16F16 inhibitor had no detectable effect
on secretion (Figures S4C–S4F). These data demonstrate
that, as in the C. elegans embryo, PDIs are important for cor-
rect Wnt secretion from human cells and are therefore funda-
mental regulators of Wnt signaling.
DISCUSSION
Wnt proteins are morphogens that can form long-range concen-
tration gradients to control developmental patterning. Multiple
regulatory mechanisms have evolved to control the amplitude,
range, and precision of Wnt-directed events. A fundamental
question is how Wnt protein folding and maturation is controlled
in Wnt-producing cells to enable secretion. Previous studies
found that Wnt secretion is controlled by the function of the ret-
romer complex and the Wnt-binding protein WIs (Ba¨nziger et al.,
2006; Coudreuse et al., 2006; Yang et al., 2008). Here, we report
the discovery of a regulatory mechanism where Wnt secretion is
controlled by PDIs.
The complexity of Wnt protein secondary structure is coordi-
nated by intracellular disulfide bonds between conserved and
invariantly positioned cysteine residues. We reasoned that spe-
cific protein chaperones may control disulfide bond formation,
which would be important for Wnt protein secretion. By genetic
screening of candidate molecules, we identified that PDI-1 is
crucial for EGL-20/Wnt gradient formation in C. elegans. To
examine the phenotypic consequence of a reduced EGL-20/
Wnt gradient in pdi-1() animals, we analyzed two well-charac-
terized EGL-20/Wnt-dependent neurodevelopmental events.
We found that PDI-1 controls the migratory capacity of the
HSN and Q cells and performs this function cell-non-autono-
mously from epidermal cells that co-express EGL-20/Wnt. ThisCell Reports 26, 3183–3190, March 19, 2019 3187
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Figure 4. A PDI Inhibitor Reduces Wnt3a
Secretion
(A–C) The 16F16 PDI inhibitor increases endoge-
nous Wnt3a protein levels without affecting tran-
scription.
(A) Endogenous Wnt3a immunofluorescence in
HEK293T cells incubated with increasing con-
centrations (0, 1, 5, and 20 mM) of 16F16 in DMSO.
Scale bar: 20 mm.
(B) Quantification of endogenous Wnt3a immu-
nofluorescence from (A) shows increased levels of
Wnt3a protein. n > 150 cells from three indepen-
dent experiments. ****p < 0.0001 compared to
DMSO control.
(C) Wnt3a transcription in HEK293T cells is not
affected by incubation with 16F16. Measure-
ments were taken in triplicate. n.s., not significant
compared to control.
(D and E) Wnt3a-V5 expression in HEK293T cells
incubated with increasing concentrations (0, 1, 5,
and 20 mM) of 16F16 in DMSO. Western blot
analysis was performed using anti-V5 (to detect
Wnt3a-V5) and anti-a-tubulin (control). Three
western blots from independent samples were
performed, a representative example of which is
shown in (D), and mean values are depicted in (E).
Data are presented as DMSO-control set to 1-fold.
*p < 0.02; **p < 0.07; ***p < 0.001; n.s., not sig-
nificant compared to DMSO-treated cells.does not, however, preclude the possibility that PDI-1 controls
the secretion and/or functional capacity of other Wnt morpho-
gens in C. elegans. The development of Wnt secretion models
for the other Wnt morphogens in C. elegans—MOM-2, LIN-44,
CWN-1, and CWN-2—would enable this interesting question to
be examined. Furthermore, other PDI proteins in C. elegans—
PDI-2, PDI-3, PDI-6, and C14B9.2—may also control secretion
of other Wnts in a tissue- and cell-specific manner. PDI expres-
sion analysis, phenotypic characterization and Wnt secretion
assays in pdi() backgrounds may identify additional regulatory
relationships between PDIs and Wnts. Indeed, differential regu-
lation of Wnt secretion by specific PDIs may reveal a regulatory3188 Cell Reports 26, 3183–3190, March 19, 2019logic, perhaps based on protein struc-
tural requirements, to facilitate precise
regulation of Wnt secretion.
We further showed that pharmacolog-
ical inhibition of PDIs causes HSN defects
that are not enhanced by pdi-1 loss. This
strongly suggests that this PDI inhibitor
can abrogate PDI-1 function in vivo. We
used the samePDI inhibitor in human cells
to show that the mechanism we revealed
is conserved, where PDI inhibition de-
creases Wnt3a secretion. A previous
study showed the importance of disulfide
bonds for human Wnt3A secretion, where
specific cysteine-to-alanine substitutions
reduced Wnt3a secretion, suggesting
that the location of unpaired cysteines
has differential effects onWnt3a secretion(MacDonald et al., 2014). In addition, wild-type Wnt3a can form
erroneous disulfide bonds during maturation, which would need
to be reconfigured prior to secretion (MacDonald et al., 2014;
Zhang et al., 2012). Our in vivo study has revealed that this func-
tion is likely performed by disulfide isomerases.
Wnt mutations identified in model organism forward genetic
screens and in human disease states also reveal the importance
of cysteine residues for Wnt function. Cysteine mutations in
the Drosophila melanogaster Wnt protein Wingless, C104S and
C242Y, cause temperature-sensitive deficits in secretion and
null phenotype, respectively (Dierick and Bejsovec, 1998; van
den Heuvel et al., 1993). For C. elegans EGL-20/Wnt, the C99S
missense mutation behaves as a null allele, whereas the C110Y
and C166Y mutations are hypomorphic (Desai et al., 1988;
Maloof et al., 1999). In human studies, cysteine mutations in
diverse Wnt proteins occur in disease. In Robinow syndrome,
characterized by short-limbed dwarfism, a causative mutation
in Wnt5a (C182R) and other mutations (C69Y and C83S) have
been identified (Person et al., 2010; Robinow et al., 1969; Roif-
man et al., 2015). In addition, a heterozygous Wnt10b mutation
(C256Y) was discovered as a potential obesity-related lesion
(Christodoulides et al., 2006). Crucially, these mutations affect
Wnt secretion and activity in vitro (Christodoulides et al., 2006;
MacDonald et al., 2014). Together, these studies support the
finding that individual cysteines have differential effects on Wnt
function and secretion (MacDonald et al., 2014). The differences
may be due to redundancy in the Wnt system, the specific
complement of Wnt proteins that are required to drive certain
developmental and homeostatic processes, and/or genetic
backgrounds. Our genetic data show that loss of PDI-1 in
C. elegans does not precisely phenocopy the EGL-20/Wnt null
(Figure 3). Therefore, a proportion of EGL-20/Wnt protein is likely
secreted and functional in pdi-1() animals. This suggests that
additional chaperones are required for folding and secretion of
Wnts in laboratory conditions.
In conclusion,Wnt protein structure is coordinated by disulfide
bonds that have differential importance forWnt secretion. During
maturation, nascent Wnt proteins can form inappropriate disul-
fide bonds (MacDonald et al., 2014; Zhang et al., 2012) that
need to be resolved prior to release to enable appropriate Wnt
signaling. Variations in disulfide bond arrangement may provide
additional flexibility for interactions between Wnts and specific
receptor molecules. Therefore, the oxidation and rearrangement
of disulfide bonds are vital and pervasive steps during Wnt
biogenesis—a function we have shown to be mediated by PDIs.STAR+METHODS
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse monoclonal anti-V5 (clone SV5-pk1) BioRad MCA1630
Rabbit polyclonal anti-Wnt3a Abcam ab199925
Mouse monoclonal anti-a-tubulin (clone 12G10) Developmental Studies
Hybridoma Bank
AB1157911
Mouse monoclonal anti-FLAG Sigma F1804
Bacterial and Virus Strains
Bacteria Escherichia coli HT115 Caenorhabditis Genetics
Center (CGC)
N/A
Genotype: E. coli [F-, mcrA, mcrB, IN(rrnD-rrnE)1,
rnc14::Tn10(DE3 lysogen: lavUV5 promoter -T7 polymerase].
Bacteria Escherichia coli OP50 (uracil auxotroph) Caenorhabditis Genetics
Center (Cgc)
N/A
Chemicals, Peptides, and Recombinant Proteins
Tetracycline Sigma 87128
16F16 Sigma SML0021
DMSO Sigmaq D2650
Sodium azide Sigma S8032-25G
DMEM Life Technologies 11960044
L-glutamine Life Technologies 25030-081
Formaldehyde (37%) Sigma F8775-25ML
Lipofectamine 2000 Thermo Fisher 11668019
2.5x LDS sample buffer Thermo Scientific B0007
Reducing agent Thermo Scientific NP0009
propidium iodide Thermo Fisher P3566
UltraPure Agarose Thermo Scientific 16500-500
Ampicillin sodium salt Sigma A9518-5G
Critical Commercial Assays
ImProm-II Reverse Transcription System Promega A3800
The LightCycler 480 SYBR Green I Master Roche 4707516001
Fast SYBR Green Master Mix Thermo Scientific 4385610
RNAeasy mini kit QIAGEN 74104
Experimental Models: Cell Lines
HEK293T- immortalized embryonic kidney cell, female
(transformed with SV40 Large T)
ATCC Cat# CRL-1573; RRID:CVCL_0045
Experimental Models: Organisms/Strains
C. elegans: Strain CF1045: muIs49[Pegl-20::egl-20::GFP] This study WormBase ID: CF1045
C. elegans: Strain RJP133: zdIs13[Ptph-1::gfp] This study RJP133
C. elegans: Strain RJP849: pdi-1(gk271); zdIs13[Ptph-1::gfp] This study RJP849
C. elegans: Strain RJP1696: egl-20(n585) zdIs13[Ptph-1::gfp] This study RJP849
C. elegans: Strain RJP1698: lin-44(n1792); zdIs13[Ptph-1::gfp] This study RJP1696
C. elegans: Strain RJP1700: cfz-2(ok1201); zdIs13[Ptph-1::gfp] This study RJP1700
C. elegans: Strain RJP1700: pdi-1(gk271); egl-20(n585) zdIs13
[Ptph-1::gfp]
This study RJP1700
C. elegans: Strain RJP1700: lin-44(n1792); pdi-1(gk271); zdIs13
[Ptph-1::gfp]
This study RJP1700
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C. elegans: Strain RJP1703: mig-1(e1787); pdi-1(gk271); zdIs13
[Ptph-1::gfp]
This study RJP1703
C. elegans: Strain RJP1704: cfz-2(ok1201); pdi-1(gk271); zdIs13
[Ptph-1::gfp]
This study RJP1704
C. elegans: Strain RJP3989: mig-1(e1787); egl-20(n585) zdIs13
[Ptph-1::gfp]
This study RJP3989
C. elegans: Strain RJP1688: rpEx715[Ppdi-1::gfp] This study RJP1688
C. elegans: Strain RJP1725: rpEx733[Pegl-20::gfp] This study RJP1725
C. elegans: Strain RJP845: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx429[Ppdi-1:: pdi-1 cDNA]
This study RJP845
C. elegans: Strain RJP1691: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx718[Ppdi-1:: pdi-1 cDNA]
This study RJP1691
C. elegans: Strain RJP1692: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx719[Ppdi-1:: pdi-1 cDNA]
This study RJP1692
C. elegans: Strain RJP842: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx426[Pdpy-7:: pdi-1 cDNA]
This study RJP842
C. elegans: Strain RJP843: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx427[Pdpy-7:: pdi-1 cDNA]
This study RJP843
C. elegans: Strain RJP844: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx428[Pdpy-7:: pdi-1 cDNA]
This study RJP844
C. elegans: Strain RJP1251: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx583[Pdpy-7:: pdi-1 cDNA -HEEL]
This study RJP1251
C. elegans: Strain RJP1252: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx584[Pdpy-7:: pdi-1 cDNA -HEEL]
This study RJP1252
C. elegans: Strain RJP1253: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx585[Pdpy-7:: pdi-1 cDNA -HEEL]
This study RJP1253
C. elegans: Strain RJP1693: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx720[Pegl-20:: pdi-1 cDNA]
This study RJP1693
C. elegans: Strain RJP1694: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx721[Pegl-20:: pdi-1 cDNA]
This study RJP1694
C. elegans: Strain RJP1695: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx722[Pegl-20:: pdi-1 cDNA]
This study RJP1695
C. elegans: Strain RJP3985: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx1717[Plin-44:: pdi-1 cDNA]
This study RJP3985
C. elegans: Strain RJP3986: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx1718[Plin-44:: pdi-1 cDNA]
This study RJP3986
C. elegans: Strain RJP3987: pdi-1(gk271); zdIs13[Ptph-1::gfp];
rpEx1719[Plin-44:: pdi-1 cDNA]
This study RJP3987
Oligonucleotides
SMARTpool: siGENOME Wnt3A siRNA Dharmacon M-008538-00-0005
Recombinant DNA
Plasmid: pPD49.26-Ppdi-1::pdi-1 This study N/A
Plasmid: Pdpy-7::pdi-1 cDNA This study N/A
Plasmid: pPD49.26-Pdpy-7::pdi-1 cDNA -HEEL rescue construct This study N/A
Plasmid: pPD49.26-Pegl-20::pdi-1 cDNA This study N/A
Plasmid: pPD49.26- Plin-44::pdi-1 cDNA This study N/A
Plasmid: pPD95.75- Pegl-20::gfp reporter This study N/A
Plasmid: pcDNA3.1(zeo)::pdi-1 cDNA::HIS tag This study N/A
Plasmid: pcDNA3.1(zeo)::egl-20 cDNA::FLAG tag This study N/A
Plasmid: pcDNA3.1(zeo)::tig-2 cDNA::FLAG tag This study N/A
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Plasmid: pPD49.26-pmyo-2::mCherry This study N/A
Plasmid: Wnt3A-V5 Addgene MacDonald et al. J
Biol Chem. 2014
43810
Software and Algorithms
ImageJ 1.47n National Institute of Health, USA N/A
Imaris 9.1.2 Bitplane N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Roger
Pocock (roger.pocock@monash.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mutant and transgenic reporter strains
Strains were grown using standard growth conditions on NGM agar at 20C on Escherichia coli OP50, unless otherwise
stated. Neuroanatomical reporter strains used -mgIs70 Is[Ptph-1::gfp]; zdIs13: Is[Ptph-1::gfp]. Detailed strain information is detailed
in Table S2.
Transgenic lines
Rescue constructs were injected into the pdi-1(gk271)mutant background at 5-15 ng/ml with Pmyo-2::mCherry (5 ng/ml) as injection
marker. Expression constructs were injected into N2 (wild-type) background at 50 ng/ml with Pmyo-2::mCherry (5 ng/ml) as injection
marker. Microinjections were performed using standard methods (Mello et al., 1991). Briefly, young adult worms were picked to an
agarose pad covered with oil on a glass slide. The immobilized worms were injected using FemtoJet 4x injector (Eppendorf)
controlled by InjectMan 4 (Eppendorf).
Primary Cell Lines
Human Embryonic Kidney cells (female) transformedwith SV40 large Twere used for transfecting withWnt3a or tig-2 plasmids and to
study endogenous Wnt3a expression.
METHOD DETAILS
Molecular cloning
Ppdi-1::pdi-1 cDNA rescue construct
The Ppdi-1::pdi-1 cDNA rescue construct was generated by cloning the 841 bp pdi-1 promoter with SphI-SmaI into the pPD49.26
vector and then the pdi-1 cDNA was cloned into this vector using NheI-SacI.
Pdpy-7::pdi-1 cDNA rescue construct
The Pdpy-7::pdi-1 cDNA rescue construct was generated by cloning pdi-1 cDNA with NheI-SacI into a dpy-7 expression vector.
Pdpy-7::pdi-1 cDNA - HEEL rescue construct
The Pdpy-7::pdi-1 cDNA -HEEL rescue construct was generated using site-directed mutagenesis to remove the 12 nucleotides that
encode HEEL at the C terminus of the PDI-1 protein.
Pegl-20::pdi-1 cDNA rescue construct
The Pegl-20::pdi-1 cDNA rescue construct was generated by cloning the 1910 bp egl-20 promoter withSphI-SmaI into the pPD49.26
vector containing the pdi-1 cDNA.
Plin-44::pdi-1 cDNA rescue construct
The Plin-44::pdi-1 cDNA rescue construct was generated by cloning the 1150 bp lin-44 promoter with SphI-SmaI into the pPD49.26
vector containing the pdi-1 cDNA.
Pegl-20::gfp reporter construct
The Pegl-20::gfp reporter construct was generated by cloning the 1910 bp egl-20 promoter with SphI-SmaI into the promoter-less
gfp pPD95.75 expression vector.
pcDNA3.1(zeo)::tig-2 cDNA::FLAG tag
The tig-2cDNA::FLAG mammalian expression construct was generated by cloning the 1098 bp tig-2 cDNA with NheI-HindIII into the
pcDNA3.1(zeo) expression vector.Cell Reports 26, 3183–3190.e1–e5, March 19, 2019 e3
RNAi experiments
RNAi feeding experiments were conducted following the Ahringer lab protocol (Fraser et al., 2000). L4440 vectors (with or without
specific dsRNA) were amplified in E. coli HT115 and selected with ampicillin and tetracycline. 100 mL of bacteria containing
L4440 vectors (with or without specific dsRNA) were inoculated on RNAi plates and dried for 24 hr. 3-5 L4 hermaphrodites were
moved onto each RNAi bacteria seeded plate and progeny were scored after 4 days as young adults. For each knockdown strain,
experiments were conducted on three independent days.
PDI inhibition in C. elegans
A 4 mM solution of the 16F16 small-molecule PDI inhibitor (Sigma - SML0021) was made using M9 buffer (0.1% DMSO final concen-
tration). Synchronized L4 hermaphrodites were incubated in 10 mL of 16F16 (4 mM) in M9 supplemented with 300 mL of concentrated
OP50 E. coli. For the control experiment, worms were incubated in 10 mL of M9 (0.1% DMSO) plus 300 mL of concentrated OP50
E. coli. Worms were shaken at 20C for 48 hours, after which they were centrifuged at 2500 rpm for 1 minute and then transferred
to standard NGM plates seeded with OP50 E. coli. HSN anatomy was scored the following day.
Fluorescence microscopy of C. elegans
Animals were anesthetized with 20 mMNaN3 on 5% agarose pads, and images were obtained with an Axio Imager M2 fluorescence
microscope and Zen software (Zeiss).
Nomarski analysis of long-range migrating neurons
The final position of Q cell descendants (QR.pax and QL.pax) and HSNs was determined using Nomarski optics in late L1 larvae. The
position of QR.pax, QL.pax and HSNs was determined with respect to the seam cell daughters V1.a to V6.p.
3D analysis of EGL-20::GFP distribution in C. elegans embryos
Comma stage wild-type and pdi-1(gk271) embryos expressing EGL-20::GFP were imaged with a Leica SP5 Confocal microscope
using a HC PL APO 63x/1.4 oil objective. Image slices of 0.22 mm were processed using Adobe illustrator CC 2018. 3D models of
embryos were generated using Imaris 9.1.2 3D interactive microscopy analysis software from Bitplane (Gopal et al., 2017).
EGL-20::GFP intensity was calculated after projecting the 3D slices to a 2D plane using FIJI image analysis software (Figure S3).
To score EGL-20::GFP distribution, embryos were divided into three zones. Zone 1 encompasses the immediate vicinity of
EGL-20::GFP-producing cells, with Zones 2 and 3 covering more distal regions. Background values were obtained from an area
of the embryo without detectable EGL-20::GFP. 15 embryos were analyzed from three independent experiments.
Endogenous Wnt3a staining of HEK293T cells
HEK293T cells were cultured overnight in 12-well tissue culture plates in DMEM containing 10% serum and 2.5 mM L-glutamine
before treating with 250 mL media containing 16F16 or DMSO for 16 h. Cells were fixed using 4% paraformaldehyde and stained
with anti-Wnt3a antibody and imaged using Zeiss PLAN-APOCHROMAT 40x/1.4 objective. Wnt3a immunofluorescence was quan-
tified using FIJI with the following formula: Corrected total fluorescence (CTF) = Integrated Density – (Area of selected cell x Mean
fluorescence of background readings). Wnt3a level from at least 150 cells from three independent experiments was measured.
The specificity of the anti-Wnt3a antibody was tested by RNAi followed by immunostaining. Briefly, a monolayer of HEK293T cells
in a 12 well plate was transfected with 50 pmol of siRNA (SMARTpool: siGENOMEWnt3A; Dharmacon; M-008538-00-0005) against
Wnt3A using Lipofectamine 2000 (Thermo Fisher, 11668019), according to manufacturer instructions. First 50 pmol of siRNA and
Lipofectamine 2000 was separately diluted in 100 ml Opti-MEM and incubated for 5 min at room temperature. The two solutions
were combined and incubated for 25 min at room temperature. After incubation, the mixture was added to the monolayer of cells.
Transfected cells were incubated at 37C for 36 hr before staining for Wnt3A protein.
Wnt3a secretion assay in HEK293T cells
HEK293T cells were cultured at 37C in 12-well tissue culture plates in DMEM containing 10% serum and 2.5 mM L-glutamine. Cells
were transfected with Wnt3a-V5 (Addgene, 43810) or TIG-2-FLAG using Lipofectamine 2000 (Thermo Fisher, 11668019), according
to manufacturer instructions. Briefly, 1.5 mg of DNA and Lipofectamine 2000 was diluted in 100 ml Opti-MEM and incubated for 5 min
at room temperature. The two solutions were combined and incubated for 25 min at room temperature. The combined solution was
added directly to the cells. After 24 h, the media was replaced with 250 mL of serum-free DMEM containing the 16F16 PDI inhibitor
(Sigma, SML0021) or DMSO. Cells were incubated at 37C for 16 h before cells and media were collected. The cells were lysed with
50 mL of 2.5x LDS sample buffer (Thermo Scientific, B0007) containing reducing agent (Thermo Scientific, NP0009). 20 mL of 2.5x LDS
sample buffer, with or without reducing agent, was added to the collected media. Samples were run on an SDS-PAGE gel before
blotting to a PVDF membrane. Membranes were probed with antibodies against FLAG (Sigma, F1804) and V5-tag (Bio-Rad,
MCA1396GA), and a-tubulin (Developmental Studies Hybridoma Bank, 12G10 anti-a-tubulin) before applying HRP conjugated sec-
ondary antibodies (Thermo Scientific). Blots were developed using BioRad ChemiDoc XRS+. Wnt3a band intensity was quantified
using FIJI image analysis software. The background was subtracted from each measurement and values were normalized first
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Fluorescence-activated cell sorting
Cell death after 16F16 treatment of HEK293T was analyzed by propidium iodide (PI) staining followed by FACS. Cells were cultured in
10 cm dishes andwere treated with 16F16 (1, 5 or 20 mM) or DMSO for 16 h, after which cells were harvested using dissociation buffer
and stained with PI at a ratio of 1:50. The percentage of PI-stained cells was determined using FACS. For each concentration, at least
100,000 cells were analyzed. The samples were gated in such away to avoid cell aggregates. PI wasmaintained in the solution during
the analysis.
qPCR assays
Total RNA was isolated using the RNAeasy minikit (QIAGEN 74104), according to manufacturer instructions. 500 ng of RNA was
reverse-transcribed to cDNA using 0.5 mg/ml oligodT primers and the ImProm-II Reverse Transcription System (A3800) followed.
cDNA was diluted to 1:5 in RNAase-free water. Quantitative PCR was performed using Light Cycler 480 (Roche) and SYBR green
(Thermo Scientific 4385610). the human Ets2 reference gene was used as a control.
QUANTIFICATION AND STATISTICAL ANALYSIS
All experiments were performed in three independent replicates. The exact numbers of animals/cells analyzed for specific experi-
ments are reported in the figure legends. Statistical analysis was performed in GraphPad Prism 7 using one-way analysis of variance
(ANOVA) for comparison followed by Dunnett’s Multiple Comparison Test or Tukey’s Multiple Comparison Test, where applicable
(Figures 1B, 1E, 2J, 3C, 3F, 4B, 4C, and S1). Values are expressed as mean ± s.d. Differences with a p value < 0.05 considered
significant. Statistical analysis of QR/QL descendants was performed using Fisher’s exact test (Figure 1D). A Monte Carlo approx-
imation, iterated 10.000 times using SPS Statistics version 22, was used to evaluate significance. Statistical analysis of EGL-20::GFP
levels and Wnt-3a secretion was performed using Welch’s t test (Figures 3I, 4E, and S4).Cell Reports 26, 3183–3190.e1–e5, March 19, 2019 e5
